Sibutramine preparations to be likely viable

Local manufacturers of sibutramine preparations are waiting for the imminent January 29 decision by the Korea Food and Drug Administration.

Market analysts predict sibutramine preparations will continue to be marketed here, as other psychotropic drugs suspected of high risk in safety is still on the market.

“We will ask members of our Central Pharmaceutical Screening Committee to take not...